Phase I Trial of Recombinant Human Interleukin-10 (SCH 52000) in Patients With Wegener's Granulomatosis
NCT00001761
·
clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
15
Enrollment
NIH
Sponsor class
Conditions
Vasculitis
Wegener's Granulomatosis
Interventions
DRUG:
Interleukin-10
Sponsor
National Institute of Allergy and Infectious Diseases (NIAID)